Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth
暂无分享,去创建一个
E. Giamarellos‐Bourboulis | K. Triantafyllou | A. Pistiki | A. Sioulas | P. Gkolfakis | K. Leventogiannis | Georgios Spithakis | Aikaterini Tsatali
[1] Lin Chang,et al. FUNCTIONAL BOWEL DISORDERS , 2018, The American Journal of Gastroenterology.
[2] H. Hallen-Adams,et al. Fungi in the healthy human gastrointestinal tract , 2017, Virulence.
[3] K. Nishida,et al. The effects of administration of the Lactobacillus gasseri strain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome , 2017, Journal of applied microbiology.
[4] M. Pimentel,et al. Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage , 2016, BMC Gastroenterology.
[5] Lixiang Li,et al. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis , 2016, BMC Gastroenterology.
[6] Clarence C Lee,et al. Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome , 2015, Scandinavian journal of gastroenterology.
[7] S. Kim,et al. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double‐blind, placebo‐controlled, multicenter, phase II trial , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[8] S. Ayis,et al. Randomised clinical trial: a liquid multi‐strain probiotic vs. placebo in the irritable bowel syndrome – a 12 week double‐blind study , 2014, Alimentary pharmacology & therapeutics.
[9] W. Chung,et al. Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double‐blind, placebo‐controlled trial , 2014, Journal of gastroenterology and hepatology.
[10] R. Gearry,et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study , 2013, International journal of clinical practice.
[11] W. Chung,et al. The Effect of a Multispecies Probiotic Mixture on the Symptoms and Fecal Microbiota in Diarrhea-dominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial , 2012, Journal of clinical gastroenterology.
[12] M. Pimentel,et al. The Prevalence of Overgrowth by Aerobic Bacteria in the Small Intestine by Small Bowel Culture: Relationship with Irritable Bowel Syndrome , 2012, Digestive Diseases and Sciences.
[13] P. Whorwell,et al. Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report , 2011, The American Journal of Gastroenterology.
[14] C. Choi,et al. A Randomized, Double-blind, Placebo-controlled Multicenter Trial of Saccharomyces boulardii in Irritable Bowel Syndrome: Effect on Quality of Life , 2011, Journal of clinical gastroenterology.
[15] O. Palsson,et al. Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients With Functional Bowel Disorders: A Double-blind Study , 2011, Journal of clinical gastroenterology.
[16] P. Shekelle,et al. Safety of Probiotics to Reduce Risk and Prevent or Treat Disease , 2011 .
[17] Pamela Sears,et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. , 2011, The New England journal of medicine.
[18] W. Chey,et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. , 2011, The New England journal of medicine.
[19] S. Vanner,et al. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS , 2010, Gut.
[20] M. Pimentel,et al. Abnormal Breath Testing in IBS: A Meta-Analysis , 2010, Digestive Diseases and Sciences.
[21] A. Gasbarrini,et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in irritable bowel syndrome , 2005, Alimentary pharmacology & therapeutics.
[22] A. Gasbarrini,et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth , 2005, Alimentary pharmacology & therapeutics.
[23] P. Whorwell,et al. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress , 1997, Alimentary pharmacology & therapeutics.
[24] P. Shekelle,et al. Safety of probiotics used to reduce risk and prevent or treat disease. , 2011, Evidence report/technology assessment.
[25] C. Nord,et al. The normal human anaerobic microflora. , 1982, Scandinavian journal of infectious diseases. Supplementum.